ES2182342T3 - Procedimiento para producir derivados de indol. - Google Patents

Procedimiento para producir derivados de indol.

Info

Publication number
ES2182342T3
ES2182342T3 ES98933651T ES98933651T ES2182342T3 ES 2182342 T3 ES2182342 T3 ES 2182342T3 ES 98933651 T ES98933651 T ES 98933651T ES 98933651 T ES98933651 T ES 98933651T ES 2182342 T3 ES2182342 T3 ES 2182342T3
Authority
ES
Spain
Prior art keywords
formula
indol
procedure
compounds
produce derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98933651T
Other languages
English (en)
Inventor
David Charles Waite
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2182342T3 publication Critical patent/ES2182342T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se refiere a un procedimiento para la producción de compuestos de fórmula (I) que comprende hacer reaccionar un compuesto de fórmula (II) con un compuesto de fórmula (III) en presencia de una base fuerte y un catalizador de paladio (0) y a una elevada temperatura y en un disolvente que no afecta negativamente a la reacción. Los compuestos de fórmula (I) se pueden procesar posteriormente hasta compuestos de fórmula (V) que son útiles en el tratamiento de, entre otros, migraña.
ES98933651T 1997-07-08 1998-06-16 Procedimiento para producir derivados de indol. Expired - Lifetime ES2182342T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714383.8A GB9714383D0 (en) 1997-07-08 1997-07-08 Improved process

Publications (1)

Publication Number Publication Date
ES2182342T3 true ES2182342T3 (es) 2003-03-01

Family

ID=10815557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98933651T Expired - Lifetime ES2182342T3 (es) 1997-07-08 1998-06-16 Procedimiento para producir derivados de indol.

Country Status (15)

Country Link
US (1) US6281357B1 (es)
EP (1) EP0975594B1 (es)
AR (1) AR013183A1 (es)
AT (1) ATE224367T1 (es)
AU (1) AU8339798A (es)
CA (1) CA2286720A1 (es)
DE (1) DE69808068T2 (es)
DK (1) DK0975594T3 (es)
ES (1) ES2182342T3 (es)
GB (1) GB9714383D0 (es)
IL (1) IL132442A0 (es)
PL (1) PL337000A1 (es)
PT (1) PT975594E (es)
WO (1) WO1999002493A1 (es)
ZA (1) ZA985918B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801690D0 (en) * 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
US6100291A (en) * 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
CA2508290C (en) 2002-12-20 2017-02-28 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
US20100022581A1 (en) * 2008-07-02 2010-01-28 Memory Pharmaceuticals Corporation Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
CN102775342A (zh) * 2011-05-12 2012-11-14 上海医药工业研究院 一种抗偏头痛药物阿莫曲坦的制备方法
RS59306B1 (sr) 2017-03-20 2019-10-31 Forma Therapeutics Inc Kompozicije pirolopirola kao aktivatori piruvat kinaze (pkr)
BR112021005188A2 (pt) 2018-09-19 2021-06-08 Forma Therapeutics, Inc. tratamento de anemia falciforme com um composto de ativação de piruvato cinase r
US12122778B2 (en) 2018-09-19 2024-10-22 Novo Nordisk Health Care Ag Activating pyruvate kinase R
CN110483341A (zh) * 2019-07-23 2019-11-22 上海药明康德新药开发有限公司 一种1-氰基-n-甲基甲磺酰胺的合成方法
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines

Also Published As

Publication number Publication date
CA2286720A1 (en) 1999-01-21
EP0975594A1 (en) 2000-02-02
US6281357B1 (en) 2001-08-28
DK0975594T3 (da) 2002-10-14
WO1999002493A1 (en) 1999-01-21
IL132442A0 (en) 2001-03-19
DE69808068T2 (de) 2003-02-06
DE69808068D1 (de) 2002-10-24
AU8339798A (en) 1999-02-08
ATE224367T1 (de) 2002-10-15
GB9714383D0 (en) 1997-09-10
PL337000A1 (en) 2000-07-31
PT975594E (pt) 2002-12-31
EP0975594B1 (en) 2002-09-18
AR013183A1 (es) 2000-12-13
ZA985918B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
ES2124062T3 (es) Derivados de nucleosido fosforotioato, sintesis y uso de los mismos.
RU95102329A (ru) Способ и стабилизированная каталитическая система для получения олефинов
ES2123149T3 (es) Derivados de perhidroisoindol como antagonistas de la substancia p.
NZ506329A (en) Inhibitors of phospholipase enzymes
ES2182342T3 (es) Procedimiento para producir derivados de indol.
GB9822473D0 (en) Chemical compounds
AR007280A1 (es) Derivados de sustancia activa, composicion y procedimiento para el tratamiento del cabello
CA2325919A1 (en) Processes for the preparation of threo-1,2-epoxy-3-amino-4-phenylbutane derivatives
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
ES2140778T3 (es) Procedimiento para la preparacion de compuestos de 2-cianoimidazol 1-sustituidos.
AR005619A1 (es) Procedimiento para preparar compuestos dicetonicos
IN187760B (es)
JPS52113974A (en) Synthesis of benzotriazole derivatives
CY1106051T1 (el) ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ Ν-ΠΡΟΣΤΑΤΕΥΜΕΝΩΝ ΑΖΕΤΙΔΙΝΟ-2-ΚΑΡΒΟΞΥΛΙΚΩΝ ΟΞΕΩΝ (AzeOHs)
TR200002755T2 (tr) Aracı hazırlamak için süreç.
GB0109093D0 (en) Process for producing photocleavable compounds
MX3341E (es) Procedimiento para la preparacion de epoxi-androstanos
EA200201233A1 (ru) Способ получения бифенильных соединений
NO991961D0 (no) FremgangsmÕte for Õ regenerere antrakinonderivater under hydrogenperoksyd-synteseprosessen
AR021005A1 (es) Procedimiento para la preparacion de cetiminas
PT1230211E (pt) Processo para a preparacao de cetiminas
BR0016204A (pt) Composição
NO994801D0 (no) FremgangsmÕte ved fremstilling av en aminalkohol
ES2191288T3 (es) Procedimiento para la preparacion de arilmalonatos.